Search

Author/Creator Duncan, Gordon W

1. Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study. Issue 5 (28th May 2021)

Authors:
Vijiaratnam, Nirosen; Girges, Christine; Auld, Grace; Chau, Marisa; Maclagan, Kate; King, Alexa; Skene, Simon; Chowdhury, Kashfia; Hibbert, Steve; Morris, Huw; Limousin, Patricia; Athauda, Dilan; Carroll, Camille B; Hu, Michele T; Silverdale, Monty; Duncan, Gordon W; Chaudhuri, Ray; Lo, Christine...
Journal:
BMJ open
Issue:
Volume 11:Issue 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. GREY MATTER AND CSF AMYLOID IN EARLY NON–DEMENTED PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION IN PARKINSON'S DISEASE (ICICLE–PD) STUDY. Issue 11 (9th October 2013)

Authors:
Duncan, Gordon W; Yarnall, Alison J; Firbank, Michael J; Barker, Roger A; O'Brien, John T; Burn, David J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 84:Issue 11(2013)
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. GREY MATTER CORRELATIONS OF COGNITIVE IMPAIRMENT IN EARLY PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION–PARKINSON'S DISEASE (ICICLE–PD) STUDY. Issue 11 (9th October 2013)

Authors:
Duncan, Gordon W; Firbank, Michael J; Yarnall, Alison J; Barker, Roger A; O'Brien, John T; Burn, David J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 84:Issue 11(2013)
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗